Rankings
▼
Calendar
MRVI
Maravai LifeSciences Holdings, Inc.
$970M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$51M
Gross Profit
$36M
70.0% margin
Operating Income
$35M
68.3% margin
Net Income
$23M
45.9% margin
EPS (Diluted)
$0.26
QoQ Revenue Growth
+41.8%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$6M
Stock-Based Comp.
$508,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$145M
Cash & Equivalents
-$25M
← FY 2020
All Quarters
Q2 2020 →
MRVI Q1 2020 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
